President Bush’s proposed budget, released February 4, for fiscal year 2009 calls for a 3.3% increase in the federal R&D investment to $145.4 billion. Federal support of basic and applied R&D would drop 0.5% to $57.1 billion, with a 3.1% increase in basic research spending to $29.3 billion and a 4.0% decrease in applied research […]
Affymetrix awarded premier application status to Beckman Coulter’s ArrayPlex application for automated target RNA preparation on the Biomek 3000. Platicell entered into an agreement with Hamilton to automate its Combinatorial Cell Culture technology for determining optimal protocols to direct stem cell differentiation. Tecan AG and pION launched the PAMPA (Parallel Artificial Membrane Permeability Assay) Explorer […]
The FDA approved 17 new molecular entities (NMEs) and two biological license applications in 2007, the lowest number of new approvals since 2002. Nine of the 19 approvals were the subject of priority review status, which is given to a drug for which few available treatments exist. Four of the new approvals were for oncology […]
Battelle and R&D Magazine estimate that federal support of R&D in 2008 will increase 2.46% to $102 billion. Industry support will increase 3.61% to $235.7 billion, 3.58% to $2.6 billion, and 3.23% to $1.4 billion with respect to the industrial, academic and nonprofit sectors. Academic R&D spending is predicted to rise 3.70% to $13 billion. […]
In the January 15 issue, IBO listed CEO changes as one of the instrument industry’s main developments of 2007. On February 1, Robert F. Friel took over as CEO of PerkinElmer, the world’s fifth largest provider of analytical and life science instrumentation (see IBO 7/31/07). He remains president. Mr. Friel told IBO that as CEO […]
Carlsbad, CA 2/15/08—Invitrogen has acquired a minority equity share in Q Therapeutics, a company developing cell therapeutic indications for the central nervous system (CNS) by purifying, culturing and growing populations of differentiated CNS cells for injection into patients.
Eppendorf AG introduced the TF Chip Stem Cell kit. Eppendorf AG and the Joint Research Center of the EU validated the firm’s DualChip GMO microarray kit. BioDiscovery released NEXUS CGH 2 software. Tecan AG introduced the QuadChamber for fully automated processing of four different microarrays simultaneously on one slide, which is validated for use with […]
According to Hong Yaxiong, deputy director of the department of policy for China’s State Environmental Protection Administration (SEPA), a new environmental ministry is likely to be created during the Eleventh National People’s Congress in March. The new ministry would assume SEPA’s duties and could also include the environmental duties of the Ministry of Land and […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
